AdaptHealth Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by AdaptHealth Corp. on December 15, 2022. The report details a corporate action authorized by the Board of Directors regarding the company's share repurchase program.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The only financial metric disclosed relates to the share repurchase program:
- Total Authorization: $200 million
- Remaining Availability (as of Dec 15, 2022): Approximately $186 million
- Funding Source: Available cash and liquidity
Material Changes
The primary material change is the extension of the existing share repurchase program. Previously set to expire on December 31, 2022, the program has been extended through December 31, 2023. No other material changes to financial position or operations are reported in this document.
Guidance, Outlook, and Risks
Management indicated that the timing and actual number of shares repurchased will depend on market conditions and other factors. The company reserves the right to start or stop purchases at any time without prior notice. The filing does not contain specific forward-looking financial guidance, risk factors, or contingencies beyond the standard discretion regarding the repurchase program.
Key Facts for Investor Verification
- Verify the exact number of shares repurchased to date to confirm the $186 million remaining balance.
- Monitor future 8-K filings or quarterly reports for actual repurchase activity under the extended program.
- Confirm the company's current cash and liquidity position to assess the ability to fund the remaining $186 million authorization.